Debate about placebos points to issue surrounded by many shades of grey.
Where this comes from
- Record sourced from PubMed, PMID 8943938.
- Also identified by PMC identifier PMC1335140.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dr. Kenneth Rothman, a critic of the use of placebos in clinical trials, recently discussed the issue with Health Canada employees. Some researchers insist this is not a black-and-white issue, and that in some cases patients who receive a placebo are the lucky ones.